Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
International Archives of Occupational and Environmental Health|November 13, 2008
Impairing effects of noise in high and low noise sensitive persons working on different mental tasksStephan Sandrock, Martin Schütte, Barbara GriefahnNoise & Health|September 14, 2007
The reliability of the noise sensitivity questionnaire in a cross-national analysisStephan Sandrock, Martin Schütte, Barbara GriefahnNoise & Health|September 14, 2007
The development of the noise sensitivity questionnaireMartin Schütte, Anke Marks, Edna Wenning, et al.European Journal of Applied Physiology|January 15, 2008
Lowering of resting core temperature during acclimation is influenced by exercise stimulusBernhard Kampmann, Peter Bröde, Martin Schütte, et al.Philosophical Transactions. Series A, Mathematical, Physical, and Engineering Sciences|April 26, 2021
Super-resolution fluorescence microscopy by line-scanning with an unmodified two-photon microscopeChristian Pilger, Jakub Pospíšil, Marcel Müller, et al.Clinical Chemistry and Laboratory Medicine|December 14, 2011
Anti-thyroid peroxidase antibodies are associated with the absence of distant metastases in patients with newly diagnosed breast cancerJamshid Farahati, Dirk Roggenbuck, Elena Gilman, et al.European Journal of Cancer (Oxford, England : 1990)|June 5, 2007
Clinical response by palpation during primary systemic therapy with four dose-dense cycles doxorubicin and docetaxel in patients with operable breast cancer: further results from a randomised controlled trialChristine Müller, Angelika Caputo, Martin Schumacher, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 20, 2005
Doxorubicin with cyclophosphamide followed by docetaxel every 21 days compared with doxorubicin and docetaxel every 14 days as preoperative treatment in operable breast cancer: the GEPARDUO study of the German Breast GroupGunter von Minckwitz, Günter Raab, Angelika Caputo, et al.Clinical Breast Cancer|November 12, 2002
Dose-dense biweekly doxorubicin/docetaxel versus sequential neoadjuvant chemotherapy with doxorubicin/cyclophosphamide/docetaxel in operable breast cancer: second interim analysisChristian Jackisch, Gunter von Minckwitz, Holger Eidtmann, et al.BMC Cancer|February 7, 2014
FemZone trial: a randomized phase II trial comparing neoadjuvant letrozole and zoledronic acid with letrozole in primary breast cancer patientsPeter A Fasching, Sebastian M Jud, Maik Hauschild, et al.Pageof 1